カテゴリー： QYResearch, 世界

世界の血友病A治療薬市場 2019年

【英語タイトル】Global Hemophilia A Drug Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X08942）・商品コード：DATA909X08942
・発行会社（調査会社）：QYResearch
・発行日：2019年11月20日（※2024年版があります。お問い合わせください）
・ページ数：114
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、血友病A治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ATXF-8117、BAY-1093884、BIVV-001、BS-027125、コンシズマブ、CSL-689、その他に、用途別には、クリニック、病院、ASCにセグメント区分し、血友病A治療薬の世界市場を分析しました。


・エグゼクティブ・サマリー
・血友病A治療薬の世界市場概要
・血友病A治療薬の製造コスト構成分析
・血友病A治療薬の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・血友病A治療薬の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・血友病A治療薬のセグメント分析（種類別）
（ATXF-8117、BAY-1093884、BIVV-001、BS-027125、コンシズマブ、CSL-689、その他）
・血友病A治療薬のセグメント分析（用途別）
（クリニック、病院、ASC）
・血友病A治療薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Bayer AG、BioMarin Pharmaceutical Inc、Bioverativ Inc、Catalyst Biosciences Inc、Chugai Pharmaceutical Co Ltd、CSL Ltd、DBV Technologies SA、Dimension Therapeutics Inc、EpiVax Inc、Expression Therapeutics LLC、Green Cross Corp、Idogen AB、Immusoft Corp、LFB SA、mAbxience SA、）
・血友病A治療薬の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Hemophilia A Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Hemophilia A Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Hemophilia A Drug market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Hemophilia A Drug in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Hemophilia A Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Bayer AG
BioMarin Pharmaceutical Inc
Bioverativ Inc
Catalyst Biosciences Inc
Chugai Pharmaceutical Co Ltd
CSL Ltd
DBV Technologies SA
Dimension Therapeutics Inc
EpiVax Inc
Expression Therapeutics LLC
Green Cross Corp
Idogen AB
Immusoft Corp
LFB SA
mAbxience SA

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
ATXF-8117
BAY-1093884
BIVV-001
BS-027125
Concizumab
CSL-689
Others

Segment by Application
Clinic
Hospital
ASCs

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Hemophilia A Drug
1.1 Definition of Hemophilia A Drug
1.2 Hemophilia A Drug Segment by Type
1.2.1 Global Hemophilia A Drug Production Growth Rate Comparison by Types (2014-2025)
1.2.2 ATXF-8117
1.2.3 BAY-1093884
1.2.4 BIVV-001
1.2.5 BS-027125
1.2.6 Concizumab
1.2.7 CSL-689
1.2.8 Others
1.3 Hemophilia A Drug Segment by Applications
1.3.1 Global Hemophilia A Drug Consumption Comparison by Applications (2014-2025)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 ASCs
1.4 Global Hemophilia A Drug Overall Market
1.4.1 Global Hemophilia A Drug Revenue (2014-2025)
1.4.2 Global Hemophilia A Drug Production (2014-2025)
1.4.3 North America Hemophilia A Drug Status and Prospect (2014-2025)
1.4.4 Europe Hemophilia A Drug Status and Prospect (2014-2025)
1.4.5 China Hemophilia A Drug Status and Prospect (2014-2025)
1.4.6 Japan Hemophilia A Drug Status and Prospect (2014-2025)
1.4.7 Southeast Asia Hemophilia A Drug Status and Prospect (2014-2025)
1.4.8 India Hemophilia A Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Hemophilia A Drug
2.3 Manufacturing Process Analysis of Hemophilia A Drug
2.4 Industry Chain Structure of Hemophilia A Drug

3 Development and Manufacturing Plants Analysis of Hemophilia A Drug
3.1 Capacity and Commercial Production Date
3.2 Global Hemophilia A Drug Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Hemophilia A Drug
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Hemophilia A Drug Production and Capacity Analysis
4.2 Hemophilia A Drug Revenue Analysis
4.3 Hemophilia A Drug Price Analysis
4.4 Market Concentration Degree

5 Hemophilia A Drug Regional Market Analysis
5.1 Hemophilia A Drug Production by Regions
5.1.1 Global Hemophilia A Drug Production by Regions
5.1.2 Global Hemophilia A Drug Revenue by Regions
5.2 Hemophilia A Drug Consumption by Regions
5.3 North America Hemophilia A Drug Market Analysis
5.3.1 North America Hemophilia A Drug Production
5.3.2 North America Hemophilia A Drug Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Hemophilia A Drug Import and Export
5.4 Europe Hemophilia A Drug Market Analysis
5.4.1 Europe Hemophilia A Drug Production
5.4.2 Europe Hemophilia A Drug Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Hemophilia A Drug Import and Export
5.5 China Hemophilia A Drug Market Analysis
5.5.1 China Hemophilia A Drug Production
5.5.2 China Hemophilia A Drug Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Hemophilia A Drug Import and Export
5.6 Japan Hemophilia A Drug Market Analysis
5.6.1 Japan Hemophilia A Drug Production
5.6.2 Japan Hemophilia A Drug Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Hemophilia A Drug Import and Export
5.7 Southeast Asia Hemophilia A Drug Market Analysis
5.7.1 Southeast Asia Hemophilia A Drug Production
5.7.2 Southeast Asia Hemophilia A Drug Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Hemophilia A Drug Import and Export
5.8 India Hemophilia A Drug Market Analysis
5.8.1 India Hemophilia A Drug Production
5.8.2 India Hemophilia A Drug Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Hemophilia A Drug Import and Export

6 Hemophilia A Drug Segment Market Analysis (by Type)
6.1 Global Hemophilia A Drug Production by Type
6.2 Global Hemophilia A Drug Revenue by Type
6.3 Hemophilia A Drug Price by Type

7 Hemophilia A Drug Segment Market Analysis (by Application)
7.1 Global Hemophilia A Drug Consumption by Application
7.2 Global Hemophilia A Drug Consumption Market Share by Application (2014-2019)

8 Hemophilia A Drug Major Manufacturers Analysis
8.1 Bayer AG
8.1.1 Bayer AG Hemophilia A Drug Production Sites and Area Served
8.1.2 Bayer AG Product Introduction, Application and Specification
8.1.3 Bayer AG Hemophilia A Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 BioMarin Pharmaceutical Inc
8.2.1 BioMarin Pharmaceutical Inc Hemophilia A Drug Production Sites and Area Served
8.2.2 BioMarin Pharmaceutical Inc Product Introduction, Application and Specification
8.2.3 BioMarin Pharmaceutical Inc Hemophilia A Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Bioverativ Inc
8.3.1 Bioverativ Inc Hemophilia A Drug Production Sites and Area Served
8.3.2 Bioverativ Inc Product Introduction, Application and Specification
8.3.3 Bioverativ Inc Hemophilia A Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Catalyst Biosciences Inc
8.4.1 Catalyst Biosciences Inc Hemophilia A Drug Production Sites and Area Served
8.4.2 Catalyst Biosciences Inc Product Introduction, Application and Specification
8.4.3 Catalyst Biosciences Inc Hemophilia A Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Chugai Pharmaceutical Co Ltd
8.5.1 Chugai Pharmaceutical Co Ltd Hemophilia A Drug Production Sites and Area Served
8.5.2 Chugai Pharmaceutical Co Ltd Product Introduction, Application and Specification
8.5.3 Chugai Pharmaceutical Co Ltd Hemophilia A Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 CSL Ltd
8.6.1 CSL Ltd Hemophilia A Drug Production Sites and Area Served
8.6.2 CSL Ltd Product Introduction, Application and Specification
8.6.3 CSL Ltd Hemophilia A Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 DBV Technologies SA
8.7.1 DBV Technologies SA Hemophilia A Drug Production Sites and Area Served
8.7.2 DBV Technologies SA Product Introduction, Application and Specification
8.7.3 DBV Technologies SA Hemophilia A Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Dimension Therapeutics Inc
8.8.1 Dimension Therapeutics Inc Hemophilia A Drug Production Sites and Area Served
8.8.2 Dimension Therapeutics Inc Product Introduction, Application and Specification
8.8.3 Dimension Therapeutics Inc Hemophilia A Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 EpiVax Inc
8.9.1 EpiVax Inc Hemophilia A Drug Production Sites and Area Served
8.9.2 EpiVax Inc Product Introduction, Application and Specification
8.9.3 EpiVax Inc Hemophilia A Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Expression Therapeutics LLC
8.10.1 Expression Therapeutics LLC Hemophilia A Drug Production Sites and Area Served
8.10.2 Expression Therapeutics LLC Product Introduction, Application and Specification
8.10.3 Expression Therapeutics LLC Hemophilia A Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Green Cross Corp
8.12 Idogen AB
8.13 Immusoft Corp
8.14 LFB SA
8.15 mAbxience SA

9 Development Trend of Analysis of Hemophilia A Drug Market
9.1 Global Hemophilia A Drug Market Trend Analysis
9.1.1 Global Hemophilia A Drug Market Size (Volume and Value) Forecast 2019-2025
9.2 Hemophilia A Drug Regional Market Trend
9.2.1 North America Hemophilia A Drug Forecast 2019-2025
9.2.2 Europe Hemophilia A Drug Forecast 2019-2025
9.2.3 China Hemophilia A Drug Forecast 2019-2025
9.2.4 Japan Hemophilia A Drug Forecast 2019-2025
9.2.5 Southeast Asia Hemophilia A Drug Forecast 2019-2025
9.2.6 India Hemophilia A Drug Forecast 2019-2025
9.3 Hemophilia A Drug Market Trend (Product Type)
9.4 Hemophilia A Drug Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Hemophilia A Drug Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Hemophilia A Drug
Table Global Hemophilia A Drug Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Hemophilia A Drug Production Market Share by Types in 2018
Figure ATXF-8117 Product Picture
Figure BAY-1093884 Product Picture
Figure BIVV-001 Product Picture
Figure BS-027125 Product Picture
Figure Concizumab Product Picture
Figure CSL-689 Product Picture
Figure Others Product Picture
Table Global Hemophilia A Drug Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Hemophilia A Drug Consumption Market Share by Applications in 2018
Figure Clinic
Figure Hospital
Figure ASCs
Figure Global Hemophilia A Drug Revenue (Million USD) (2014-2025)
Figure Global Hemophilia A Drug Production (K Pcs) (2014-2025)
Figure North America Hemophilia A Drug Market Size (Million USD) (2014-2025)
Figure Europe Hemophilia A Drug Market Size (Million USD) (2014-2025)
Figure China Hemophilia A Drug Market Size (Million USD) (2014-2025)
Figure Japan Hemophilia A Drug Market Size (Million USD) (2014-2025)
Figure Southeast Asia Hemophilia A Drug Market Size (Million USD) (2014-2025)
Figure India Hemophilia A Drug Market Size (Million USD) (2014-2025)
Table Hemophilia A Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Hemophilia A Drug in 2018
Figure Manufacturing Process Analysis of Hemophilia A Drug
Figure Industry Chain Structure of Hemophilia A Drug
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Hemophilia A Drug Manufacturing Plants Distribution
Table Hemophilia A Drug Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Hemophilia A Drug Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Hemophilia A Drug Production (K Pcs) of Major Manufacturers (2014-2019)
Table Hemophilia A Drug Production Market Share of Major Manufacturers (2014-2019)
Figure Hemophilia A Drug Production Share by Manufacturers in 2018
Table Hemophilia A Drug Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Hemophilia A Drug Revenue Market Share of Major Manufacturers (2014-2019)
Figure Hemophilia A Drug Revenue Share by Manufacturers in 2018
Table Hemophilia A Drug Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Hemophilia A Drug Production by Regions 2014-2019 (K Pcs)
Table Global Hemophilia A Drug Production Market Share by Regions 2014-2019
Figure Global Hemophilia A Drug Production Market Share by Regions in 2018
Table Global Hemophilia A Drug Revenue by Regions 2014-2019 (Million USD)
Table Global Hemophilia A Drug Revenue Market Share by Regions 2014-2019
Figure Global Hemophilia A Drug Revenue Market Share by Regions in 2018
Table Global Hemophilia A Drug Consumption by Regions 2014-2019 (K Pcs)
Table Global Hemophilia A Drug Consumption Market Share by Regions 2014-2019
Figure North America Hemophilia A Drug Production Growth Rate 2014-2019 (K Pcs)
Figure North America Hemophilia A Drug Revenue Growth Rate 2014-2019 (Million USD)
Table North America Hemophilia A Drug Production, Consumption Import and Export (K Pcs)
Figure Europe Hemophilia A Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Hemophilia A Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Hemophilia A Drug Production, Consumption Import and Export (K Pcs)
Figure China Hemophilia A Drug Production Growth Rate 2014-2019 (K Pcs)
Figure China Hemophilia A Drug Revenue Growth Rate 2014-2019 (Million USD)
Table China Hemophilia A Drug Production, Consumption Import and Export (K Pcs)
Figure Japan Hemophilia A Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Hemophilia A Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Hemophilia A Drug Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Hemophilia A Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Hemophilia A Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Hemophilia A Drug Production, Consumption Import and Export (K Pcs)
Figure India Hemophilia A Drug Production Growth Rate 2014-2019 (K Pcs)
Figure India Hemophilia A Drug Revenue Growth Rate 2014-2019 (Million USD)
Table India Hemophilia A Drug Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Hemophilia A Drug Market Share by Application (2014-2019)
Figure Global Value (Consumption) Hemophilia A Drug Market Share by Application (2014-2019)
Table Bayer AG Hemophilia A Drug Production Sites and Area Served
Table Bayer AG Hemophilia A Drug Product Introduction, Application and Specification
Table Bayer AG Hemophilia A Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Bayer AG Hemophilia A Drug Production Growth Rate (2014-2019)
Table Bayer AG Hemophilia A Drug Production Market Share (2014-2019)
Figure Bayer AG Hemophilia A Drug Revenue Market Share (2014-2019)
Table Bayer AG Hemophilia A Drug Main Business and Markets Served
Table BioMarin Pharmaceutical Inc Hemophilia A Drug Production Sites and Area Served
Table BioMarin Pharmaceutical Inc Hemophilia A Drug Product Introduction, Application and Specification
Table BioMarin Pharmaceutical Inc Hemophilia A Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table BioMarin Pharmaceutical Inc Hemophilia A Drug Production Growth Rate (2014-2019)
Table BioMarin Pharmaceutical Inc Hemophilia A Drug Production Market Share (2014-2019)
Figure BioMarin Pharmaceutical Inc Hemophilia A Drug Revenue Market Share (2014-2019)
Table BioMarin Pharmaceutical Inc Hemophilia A Drug Main Business and Markets Served
Table Bioverativ Inc Hemophilia A Drug Production Sites and Area Served
Table Bioverativ Inc Hemophilia A Drug Product Introduction, Application and Specification
Table Bioverativ Inc Hemophilia A Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Bioverativ Inc Hemophilia A Drug Production Growth Rate (2014-2019)
Table Bioverativ Inc Hemophilia A Drug Production Market Share (2014-2019)
Figure Bioverativ Inc Hemophilia A Drug Revenue Market Share (2014-2019)
Table Bioverativ Inc Hemophilia A Drug Main Business and Markets Served
Table Catalyst Biosciences Inc Hemophilia A Drug Production Sites and Area Served
Table Catalyst Biosciences Inc Hemophilia A Drug Product Introduction, Application and Specification
Table Catalyst Biosciences Inc Hemophilia A Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Catalyst Biosciences Inc Hemophilia A Drug Production Growth Rate (2014-2019)
Table Catalyst Biosciences Inc Hemophilia A Drug Production Market Share (2014-2019)
Figure Catalyst Biosciences Inc Hemophilia A Drug Revenue Market Share (2014-2019)
Table Catalyst Biosciences Inc Hemophilia A Drug Main Business and Markets Served
Table Chugai Pharmaceutical Co Ltd Hemophilia A Drug Production Sites and Area Served
Table Chugai Pharmaceutical Co Ltd Hemophilia A Drug Product Introduction, Application and Specification
Table Chugai Pharmaceutical Co Ltd Hemophilia A Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Chugai Pharmaceutical Co Ltd Hemophilia A Drug Production Growth Rate (2014-2019)
Table Chugai Pharmaceutical Co Ltd Hemophilia A Drug Production Market Share (2014-2019)
Figure Chugai Pharmaceutical Co Ltd Hemophilia A Drug Revenue Market Share (2014-2019)
Table Chugai Pharmaceutical Co Ltd Hemophilia A Drug Main Business and Markets Served
Table CSL Ltd Hemophilia A Drug Production Sites and Area Served
Table CSL Ltd Hemophilia A Drug Product Introduction, Application and Specification
Table CSL Ltd Hemophilia A Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table CSL Ltd Hemophilia A Drug Production Growth Rate (2014-2019)
Table CSL Ltd Hemophilia A Drug Production Market Share (2014-2019)
Figure CSL Ltd Hemophilia A Drug Revenue Market Share (2014-2019)
Table CSL Ltd Hemophilia A Drug Main Business and Markets Served
Table DBV Technologies SA Hemophilia A Drug Production Sites and Area Served
Table DBV Technologies SA Hemophilia A Drug Product Introduction, Application and Specification
Table DBV Technologies SA Hemophilia A Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table DBV Technologies SA Hemophilia A Drug Production Growth Rate (2014-2019)
Table DBV Technologies SA Hemophilia A Drug Production Market Share (2014-2019)
Figure DBV Technologies SA Hemophilia A Drug Revenue Market Share (2014-2019)
Table DBV Technologies SA Hemophilia A Drug Main Business and Markets Served
Table Dimension Therapeutics Inc Hemophilia A Drug Production Sites and Area Served
Table Dimension Therapeutics Inc Hemophilia A Drug Product Introduction, Application and Specification
Table Dimension Therapeutics Inc Hemophilia A Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Dimension Therapeutics Inc Hemophilia A Drug Production Growth Rate (2014-2019)
Table Dimension Therapeutics Inc Hemophilia A Drug Production Market Share (2014-2019)
Figure Dimension Therapeutics Inc Hemophilia A Drug Revenue Market Share (2014-2019)
Table Dimension Therapeutics Inc Hemophilia A Drug Main Business and Markets Served
Table EpiVax Inc Hemophilia A Drug Production Sites and Area Served
Table EpiVax Inc Hemophilia A Drug Product Introduction, Application and Specification
Table EpiVax Inc Hemophilia A Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table EpiVax Inc Hemophilia A Drug Production Growth Rate (2014-2019)
Table EpiVax Inc Hemophilia A Drug Production Market Share (2014-2019)
Figure EpiVax Inc Hemophilia A Drug Revenue Market Share (2014-2019)
Table EpiVax Inc Hemophilia A Drug Main Business and Markets Served
Table Expression Therapeutics LLC Hemophilia A Drug Production Sites and Area Served
Table Expression Therapeutics LLC Hemophilia A Drug Product Introduction, Application and Specification
Table Expression Therapeutics LLC Hemophilia A Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Expression Therapeutics LLC Hemophilia A Drug Production Growth Rate (2014-2019)
Table Expression Therapeutics LLC Hemophilia A Drug Production Market Share (2014-2019)
Figure Expression Therapeutics LLC Hemophilia A Drug Revenue Market Share (2014-2019)
Table Expression Therapeutics LLC Hemophilia A Drug Main Business and Markets Served
Table Green Cross Corp Hemophilia A Drug Production Sites and Area Served
Table Idogen AB Hemophilia A Drug Production Sites and Area Served
Table Immusoft Corp Hemophilia A Drug Production Sites and Area Served
Table LFB SA Hemophilia A Drug Production Sites and Area Served
Table mAbxience SA Hemophilia A Drug Production Sites and Area Served
Figure Global Hemophilia A Drug Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Hemophilia A Drug Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Hemophilia A Drug Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Hemophilia A Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Hemophilia A Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Hemophilia A Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Hemophilia A Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Hemophilia A Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Hemophilia A Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Hemophilia A Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Hemophilia A Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Hemophilia A Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Hemophilia A Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Hemophilia A Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Hemophilia A Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Hemophilia A Drug by Type (2019-2025)
Table Global Consumption (K Pcs) of Hemophilia A Drug by Application (2019-2025)
Table Hemophilia A Drug Distributors List
Table Hemophilia A Drug Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Bayer AG、BioMarin Pharmaceutical Inc、Bioverativ Inc、Catalyst Biosciences Inc、Chugai Pharmaceutical Co Ltd、CSL Ltd、DBV Technologies SA、Dimension Therapeutics Inc、EpiVax Inc、Expression Therapeutics LLC、Green Cross Corp、Idogen AB、Immusoft Corp、LFB SA、mAbxience SA、

★調査レポート[世界の血友病A治療薬市場 2019年] (コード：DATA909X08942)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の血友病A治療薬市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の甲状腺機能低下症薬市場 2019年
    DATA909X09522 / QYResearch / 2019年11月20日 / ※本調査レポートは、甲状腺機能低下症薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、BCT-305、GX-30、レボチロキシンナトリウムSR、リオチロニン、その他に、用途別には、病院、診療所、その他にセグメント区分し、甲状腺機能低下症薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・甲状腺機能低下症薬の世界市場概要 ・甲状腺機能低下症薬の製造コスト構成分析 ・甲状腺機能低下症薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・甲状腺機能低下症薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・甲状腺機能低下症薬のセグメント分析（種類別） （BCT-305、GX-30、レボチロキシンナトリウムSR、リオチロニン、その他）...The global Hypothyroidism Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Hypothyroidism Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Hypothyroidism Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Hypothyroidism Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their Hypothyroidism Drug manufacturing...
  • 世界のタミフル（オセルタミビル）薬市場 2019年
    DATA909X16262 / QYResearch / 2019年11月22日 / ※本調査レポートは、タミフル（オセルタミビル）薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、カプセル、経口液に、用途別には、インフルエンザA、インフルエンザBにセグメント区分し、タミフル（オセルタミビル）薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・タミフル（オセルタミビル）薬の世界市場概要 ・タミフル（オセルタミビル）薬の製造コスト構成分析 ・タミフル（オセルタミビル）薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・タミフル（オセルタミビル）薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・タミフル（オセルタミビル）薬のセグメント分析（種類別） （カプセル、経口液）...The global Tamiflu (Oseltamivir) Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Tamiflu (Oseltamivir) Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Tamiflu (Oseltamivir) Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Tamiflu (Oseltamivir) Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界のコクシジオイデス症薬剤市場 2019年
    DATA909X05597 / QYResearch / 2019年11月15日 / ※本調査レポートは、コクシジオイデス症薬剤の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、VT-1161、APX-001、VT-1598、ニッコマイシンZ、その他に、用途別には、クリニック、病院、その他にセグメント区分し、コクシジオイデス症薬剤の世界市場を分析しました。 ・エグゼクティブ・サマリー ・コクシジオイデス症薬剤の世界市場概要 ・コクシジオイデス症薬剤の製造コスト構成分析 ・コクシジオイデス症薬剤の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・コクシジオイデス症薬剤の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・コクシジオイデス症薬剤のセグメント分析（種類別） （VT-1161、APX-001、VT-1598、ニッコマイシンZ、その他）...The global Coccidioidomycosis Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Coccidioidomycosis Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Coccidioidomycosis Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Coccidioidomycosis Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their Coccidioidomycosis Drug manufacturing...
  • 世界のファンコニ貧血薬市場 2019年
    DATA909X07597 / QYResearch / 2019年11月15日 / ※本調査レポートは、ファンコニ貧血薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、エルトロンボパグオラミン、EXG-34217、ファンカレン、その他に、用途別には、病院、診療所、その他にセグメント区分し、ファンコニ貧血薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・ファンコニ貧血薬の世界市場概要 ・ファンコニ貧血薬の製造コスト構成分析 ・ファンコニ貧血薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・ファンコニ貧血薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・ファンコニ貧血薬のセグメント分析（種類別） （エルトロンボパグオラミン、EXG-34217、ファンカレン、その他）...The global Fanconi Anemia Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Fanconi Anemia Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Fanconi Anemia Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Fanconi Anemia Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界の勃起不全（ED）薬市場 2019年
    DATA909X07425 / QYResearch / 2019年11月15日 / ※本調査レポートは、勃起不全（ED）薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、バルデナフィル、アバナフィル、タダラフィル、バルデナフィルに、用途別には、スーパーマーケット、オンラインストア、薬局、その他にセグメント区分し、勃起不全（ED）薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・勃起不全（ED）薬の世界市場概要 ・勃起不全（ED）薬の製造コスト構成分析 ・勃起不全（ED）薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・勃起不全（ED）薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・勃起不全（ED）薬のセグメント分析（種類別） （バルデナフィル、アバナフィル、タダラフィル、バルデナフィル）...The global Erectile Dysfunction(ED) Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Erectile Dysfunction(ED) Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Erectile Dysfunction(ED) Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Erectile Dysfunction(ED) Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...

    • ◆H&Iグローバルリサーチのお客様（例）◆